Johnson & Johnson News
Johnson & Johnson Pharmaceutical Company News
Television Star Alison Sweeney Joins ZYRTEC® to Welcome the Arrival of Spring with the 'Race Against Your Allergies'(Mar 19, 2010)
Ft. Washington, PA (March 19 2010) -- Allergy sufferer and actress Alison Sweeney today joined the makers of the fastest 24-hour over-the-counter (OTC) allergy medicine, ZYRTEC®,for an unusual race to officially welcome the first day of spring and new ZYRTEC® Liquid Gels.
Human Performance Institute, Inc. Announces Agreement With Claremont Hotel Club & Spa to Bring its Corporate Athlete® Course to Clients in Bay Area(Mar 17, 2010)
Orlando, FL (March 17, 2010) – Human Performance Institute, Inc.® (HPI) announced today it has partnered with Berkeley, California-based Claremont Hotel Club & Spa to host HPI’s Corporate Athlete® Course, an executive leadership training.
Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the CYPHER® Sirolimus Drug-Eluting Stent over the Endeavor® Zotarolimus-Eluting Stent(Mar 15, 2010)
Bridgewater,NJ (March 15, 2010) Investigators reported the long-term follow-up of the largest randomized comparison between the CYPHER® Sirolimus-eluting Coronary Stent and Medtronic’s Endeavor® Stent highlighting significant and sustained clinical differences.
ASP Offers Safety and Convenience to Those Transitioning from 'Just-in-Time' Sterilization to Terminal Sterilization with the Introduction of the ASP OR Solution(Mar 15, 2010)
Denver, CO (March 15, 2010) -- Raising the standards of care in the Operating Room by transitioning from "just-in-time" to terminal sterilization can now be achieved conveniently and effectively with the new Operating Room (OR) Solution from Advanced Sterilization Products (ASP).
PRILIGY® - New approved medication for Premature Ejaculation available for New Zealand (Mar 12, 2010)
New Zealand Press Association
Introducing NEUTROGENA CLINICAL™ with ION2COMPLEX™ Technology(Mar 11, 2010)
Los Angeles, CA (March 11 2010) -- After years of research and ten new technology patents, Neutrogena®, the #1 dermatologist-recommend skin care brand, introduces NEUTROGENA CLINICAL™, featuring a breakthrough new anti-aging technology known as ION2COMPLEX™ to revitalize the look of collagen-depleted skin.....
Cordis Unveils Next Generation CoCr Coronary Stent(Mar 11, 2010)
Waterloo, Belgium (March 11, 2010) -- Cordis Corporation today announced the European launch of its next generation of bare metal stent system - PRESILLION™ PLUS. The new stent system, which improves upon the ground-breaking PRESILLION™, features important technological advances designed to gain easier access to distal lesions and help restore the artery's natural form.....
Market acceptance of virco®TYPE HIV-1 continues to grow, Virco BVBA to discontinue Antivirogram® for the routine HIV clinical market.(Mar 10, 2010)
Mechelen, Belgium, 8th March 2010: Due to declining demand for the Antivirogram® in the US and other markets, Virco BVBA announced that as of April 26th, 2010, it will no longer offer this service for routine clinical use. The test will remain available for research and the drug discovery and development market.....
ACUVUE® Brand Contact Lenses Celebrates Spring with A Chance to Win A $10,000 Shopping Spree(Mar 10, 2010)
Jacksonville, FL (March 10, 2010) – VISTAKON, Division of Johnson & Johnson Vision Care, Inc., and makers of ACUVUE Brand Contact Lenses, today announced the ACUVUE SEE SPRING Sweepstakes.....
Market acceptance of virco®TYPE HIV-1 continues to grow, Virco BVBA to discontinue Antivirogram® for the routine HIV clinical market.(Mar 9, 2010)
Mechelen, Belgium, 8th March 2010: Due to declining demand for the Antivirogram® in the US and other markets, Virco BVBA announced that as of April 26th, 2010, it will no longer offer this service for routine clinical use. The test will remain available for research and the drug discovery and development market.....
